Literature DB >> 18241800

Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine.

Quansheng Zhou1, William B Kiosses, Jin Liu, Paul Schimmel.   

Abstract

In addition to their key role in protein biosynthesis, aminoacyl-tRNA synthetases have other biological functions that appeared during their long evolutionary development. In mammalian cells, specific members of this family of enzymes are also procytokines that, upon conversion, are active cytokines in pathways for angiogenesis, and thereby connect translation to control of blood vessel development. Here we describe an in vitro assay for tube formation by tumor endothelial cells on a matrigel substrate. In contrast to normal endothelial cells, tumor endothelial cells have strong angiogenic capabilities and the ability to form vessel-like tubes on a solid substrate. In particular, we found that a SV40-immortalized mouse lymphoid endothelial cell line was robust in this assay and yielded data that could be quantified with high precision. Consequently, this specific tube formation model provides an opportunity to discover and analyze potent agents that specifically affect angiogenesis. It has proven effective for studying the angiogenic functions of tRNA synthetase cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241800      PMCID: PMC3835186          DOI: 10.1016/j.ymeth.2007.10.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  22 in total

1.  A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Authors:  Atsushi Otani; Bonnie M Slike; Michael I Dorrell; John Hood; Karen Kinder; Karla L Ewalt; David Cheresh; Paul Schimmel; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 3.  The early history of tRNA recognition by aminoacyl-tRNA synthetases.

Authors:  Richard Giegé
Journal:  J Biosci       Date:  2006-10       Impact factor: 1.826

Review 4.  Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs.

Authors:  P Schimmel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo.

Authors:  G Alessandri; K Raju; P M Gullino
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

6.  Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase.

Authors:  Keisuke Wakasugi; Bonnie M Slike; John Hood; Karla L Ewalt; David A Cheresh; Paul Schimmel
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

7.  A dominant-negative p65 PAK peptide inhibits angiogenesis.

Authors:  William B Kiosses; John Hood; Suya Yang; Mary E Gerritsen; David A Cheresh; Nazilla Alderson; Martin Alexander Schwartz
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

8.  A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase.

Authors:  Yoshiaki Kise; Sang Won Lee; Sang Gyu Park; Shuya Fukai; Toru Sengoku; Ryohei Ishii; Shigeyuki Yokoyama; Sunghoon Kim; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2004-01-11       Impact factor: 15.369

Review 9.  Relationship of two human tRNA synthetases used in cell signaling.

Authors:  Xiang-Lei Yang; Paul Schimmel; Karla L Ewalt
Journal:  Trends Biochem Sci       Date:  2004-05       Impact factor: 13.807

10.  Murine endothelial cell lines as models of tumor endothelial cells.

Authors:  Jennifer Walter-Yohrling; Sharon Morgenbesser; Cecile Rouleau; Rebecca Bagley; Michelle Callahan; William Weber; Beverly A Teicher
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more
  12 in total

1.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

2.  Brain regional angiogenic potential at the neurovascular unit during normal aging.

Authors:  Nivetha Murugesan; Tyler G Demarest; Joseph A Madri; Joel S Pachter
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

3.  The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.

Authors:  Ryan M Thomas; Dawn V Jaquish; Randall P French; Andrew M Lowy
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

4.  Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.

Authors:  Florence Schaffner; Henri H Versteeg; Anja Schillert; Naho Yokota; Lars C Petersen; Barbara M Mueller; Wolfram Ruf
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

5.  The plasminogen receptor, Plg-RKT, is essential for mammary lobuloalveolar development and lactation.

Authors:  L A Miles; N Baik; H Bai; H P Makarenkova; W B Kiosses; S Krajewski; F J Castellino; A Valenzuela; N M Varki; B M Mueller; R J Parmer
Journal:  J Thromb Haemost       Date:  2018-04-01       Impact factor: 5.824

Review 6.  Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.

Authors:  Bingxue Shang; Zhifei Cao; Quansheng Zhou
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

7.  Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality.

Authors:  Quansheng Zhou; Mili Kapoor; Min Guo; Rajesh Belani; Xiaoling Xu; William B Kiosses; Melanie Hanan; Chulho Park; Eva Armour; Minh-Ha Do; Leslie A Nangle; Paul Schimmel; Xiang-Lei Yang
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

8.  Paracrine induction of endothelium by tumor exosomes.

Authors:  Joshua L Hood; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Lab Invest       Date:  2009-09-28       Impact factor: 5.662

9.  The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts.

Authors:  Tracy E Strecker; Samuel O Odutola; Ramona Lopez; Morgan S Cooper; Justin K Tidmore; Amanda K Charlton-Sevcik; Li Li; Matthew T MacDonough; Mallinath B Hadimani; Anjan Ghatak; Li Liu; David J Chaplin; Ralph P Mason; Kevin G Pinney; Mary Lynn Trawick
Journal:  Cancer Lett       Date:  2015-09-01       Impact factor: 8.679

10.  Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells.

Authors:  Xing-dong Xu; Lan Yang; Li-yun Zheng; Yan-yan Pan; Zhi-fei Cao; Zhi-qing Zhang; Quan-sheng Zhou; Bo Yang; Cong Cao
Journal:  BMC Cancer       Date:  2014-05-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.